High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Weiss, Gisela Adrienne ^a,b   Troxler, Heinz ^a   Klinke, Glynis ^a,b   Rogler, Daniela ^a   Braegger, Christian ^a   Hersberger, Martin ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

15 HETE; 17 HDHA; 18 HEPE; DHA; EPA; Human milk; Leukotrienes; Lipoxins; Omega 3 fatty acids; Resolvins

Indexed keywords

ARACHIDONIC ACID; AUTACOID; BEHENIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; GAMMA LINOLENIC ACID; HYDROXY FATTY ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE B4; LIGNOCERIC ACID; LINOLEIC ACID; LINOLENIC ACID; LIPOXIN; LIPOXIN A; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; RESOLVIN D1; RESOLVIN E1; STEARIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BREAST MILK; FOOD COMPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTATION; LIPID COMPOSITION; MASS FRAGMENTOGRAPHY; TANDEM MASS SPECTROMETRY;

DOCOSAHEXAENOIC ACIDS; EICOSANOIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; LACTATION; LIPID METABOLISM; LIPOXINS; MILK, HUMAN; UNITED STATES;

EID: 84878894840     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-89     Document Type: Article

References (86)

1. Fatty acids in early human milk after preterm and full-term delivery. Kovacs A, Funke S, Marosvolgyi T, Burus I, Decsi T, J Pediatr Gastroenterol Nutr 2005 41 454 459 10.1097/01.mpg.0000176181.66390.54 16205514 (Pubitemid 41407608)
2. Systematic review of fatty acid composition of human milk from mothers of preterm compared to full-term infants. Bokor S, Koletzko B, Decsi T, Ann Nutr Metab 2007 51 550 556 10.1159/000114209 18227623 (Pubitemid 351315921)
3. Long chain polyunsaturated fatty acids in mothers of preterm babies. Kilari AS, Mehendale SS, Dangat KD, Yadav HR, Gupta A, Taralekar VS, Joshi SR, J Perinat Med 2010 38 659 664 20807011
4. Long chain polyunsaturated fatty acids in mothers and term babies. Kilari AS, Mehendale SS, Dangat KD, Yadav HR, Kulakarni AV, Dhobale MV, Taralekar VS, Joshi SR, J Perinat Med 2009 37 513 518 19492914
5. Changes in the fatty acid composition of preterm and term human milk from 1 week to 6 months of lactation. Luukkainen P, Salo MK, Nikkari T, J Pediatr Gastroenterol Nutr 1994 18 355 360 10.1097/00005176-199404000-00018 8057221 (Pubitemid 24125850)
6. Breast milk composition: fat content and fatty acid composition in vegetarians and non-vegetarians. Finley DA, Lonnerdal B, Dewey KG, Grivetti LE, Am J Clin Nutr 1985 41 787 800 3984932 (Pubitemid 15092889)
7. Probiotics and dietary counselling targeting maternal dietary fat intake modifies breast milk fatty acids and cytokines. Hoppu U, Isolauri E, Laakso P, Matomaki J, Laitinen K, Eur J Nutr 2012 51 211 219 10.1007/s00394-011-0209-0 21626296
8. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Dunstan JA, Mitoulas LR, Dixon G, Doherty DA, Hartmann PE, Simmer K, Prescott SL, Pediatr Res 2007 62 689 694 10.1203/PDR.0b013e318159a93a 17957152 (Pubitemid 350158807)
9. Vitamin E, lipid fractions, and fatty acid composition of colostrum, transitional milk, and mature milk: an international comparative study. Boersma ER, Offringa PJ, Muskiet FA, Chase WM, Simmons IJ, Am J Clin Nutr 1991 53 1197 1204 2021129
10. Changes in the polyunsaturated fatty acids of breast milk from mothers of full-term infants over 30 wk of lactation. Makrides M, Simmer K, Neumann M, Gibson R, Am J Clin Nutr 1995 61 1231 1233 7762522
11. Long-chain polyunsaturated fatty acids in human milk. Agostoni C, Marangoni F, Bernardo L, Lammardo AM, Galli C, Riva E, Acta Paediatr Suppl 1999 88 68 71 10569226 (Pubitemid 29489146)
12. Fatty acid profile of human milk of Portuguese lactating women: prospective study from the 1st to the 16th week of lactation. Ribeiro M, Balcao V, Guimaraes H, Rocha G, Moutinho C, Matos C, Almeida C, Casal S, Guerra A, Ann Nutr Metab 2008 53 50 56 10.1159/000156597 18802330
13. Changes in the lipids of human milk from 2 to 16 weeks postpartum. Clark RM, Ferris AM, Fey M, Brown PB, Hundrieser KE, Jensen RG, J Pediatr Gastroenterol Nutr 1982 1 311 315 10.1097/00005176-198201030-00006 7186044 (Pubitemid 13247120)
14. Fatty acid composition of Taiwanese human milk. Wu TC, Lau BH, Chen PH, Wu LT, Tang RB, Journal of the Chinese Medical Association: JCMA 2010 73 581 588 10.1016/S1726-4901(10)70127-1 21093826
15. Changing patterns of human milk lipids in the course of the lactation and during the day. Harzer G, Haug M, Dieterich I, Gentner PR, Am J Clin Nutr 1983 37 612 621 6682283 (Pubitemid 13057051)
16. Fatty acid composition of human breast milk. Rodkiewicz B, Hardell LI, Pawlikowska-Rojewska B, Tuvemo T, Changes during the first week after delivery. Upsala journal of medical sciences 1981 86 279 289
17. Uniformity of human milk. Hall B, Am J Clin Nutr 1979 32 304 312 570353 (Pubitemid 9129256)
18. Fatty acid patterns of human milk. Guthrie HA, Picciano MF, Sheehe D, J Pediatr 1977 90 39 41 10.1016/S0022-3476(77)80761-0 830891 (Pubitemid 8015629)
19. Essential fatty acids and human tissue composition An overview. Ballabriga A, Acta Paediatr Suppl 1994 402 63 68 7841625 (Pubitemid 24335806)
20. Long-chain polyunsaturated fatty acids and development of human infants. Carlson SE, Acta Paediatr Suppl 1999 88 72 77 10588274 (Pubitemid 29489147)
21. The role of docosahexaenoic acid in retinal function. Jeffrey BG, Weisinger HS, Neuringer M, Mitchell DC, Lipids 2001 36 859 871 10.1007/s11745-001-0796-3 11724458 (Pubitemid 33065187)
22. Relation between polyunsaturated fatty acids and growth. Xiang M, Zetterstrom R, Acta Paediatr Suppl 1999 88 78 82 10626550 (Pubitemid 29489148)
23. Associations between fatty acids in colostrum and breast milk and risk of allergic disease. Lowe AJ, Thien FC, Stoney RM, Bennett CM, Hosking CS, Hill DJ, Carlin JB, Abramson MJ, Dharmage SC, Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 2008 38 1745 1751
24. Maternal breast milk long-chain n-3 fatty acids are associated with increased risk of atopy in breastfed infants. Stoney RM, Woods RK, Hosking CS, Hill DJ, Abramson MJ, Thien FC, Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 2004 34 194 200 10.1111/j.1365-2222.2004.01852.x (Pubitemid 38315254)
25. Breast milk fatty acids may link innate and adaptive immune regulation: analysis of soluble CD14, prostaglandin E2, and fatty acids. Laitinen K, Hoppu U, Hamalainen M, Linderborg K, Moilanen E, Isolauri E, Pediatr Res 2006 59 723 727 10.1203/01.pdr.0000203158.31452.9e 16627889 (Pubitemid 43740019)
26. Human milk polyunsaturated long-chain fatty acids and secretory immunoglobulin A antibodies and early childhood allergy. Duchen K, Casas R, Fageras-Bottcher M, Yu G, Bjorksten B, Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology 2000 11 29 39 (Pubitemid 30168882)
27. Fatty acids and immune function: relevance to inflammatory bowel diseases. Calder PC, Int Rev Immunol 2009 28 506 534 10.3109/08830180903197480 19954361
28. Fatty acids and inflammation: the cutting edge between food and pharma. Calder PC, Eur J Pharmacol 2011 668 Suppl 1 50 S58 21816146
29. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Shimizu T, Annu Rev Pharmacol Toxicol 2009 49 123 150 10.1146/annurev.pharmtox.011008. 145616 18834304
30. Novel anti-inflammatory-pro-resolving mediators and their receptors. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N, Curr Top Med Chem 2011 11 629 647 10.2174/1568026611109060629 21261595
31. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Hersberger M, Clinical chemistry and laboratory medicine: CCLM / FESCC 2010 48 1063 1073
32. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL, J Exp Med 2002 196 1025 1037 10.1084/jem.20020760 12391014 (Pubitemid 35231761)
33. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN, J Exp Med 2005 201 713 722 10.1084/jem.20042031 15753205 (Pubitemid 40395117)
34. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. Oh SF, Pillai PS, Recchiuti A, Yang R, Serhan CN, J Clin Invest 2011 121 569 581 10.1172/JCI42545 21206090
35. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR, J Immunol 2000 164 1663 1667 10657608 (Pubitemid 30108713)
36. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. Maddox JF, Serhan CN, J Exp Med 1996 183 137 146 10.1084/jem.183.1.137 8551217 (Pubitemid 26028753)
37. Molecular circuits of resolution: formation and actions of resolvins and protectins. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN, J Immunol 2005 174 4345 4355 15778399 (Pubitemid 40396017)
38. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM, J Exp Med 2006 203 837 842 10.1084/jem.20052371 16567388
39. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Yacoubian S, Serhan CN, Nature clinical practice Rheumatology 2007 3 570 579 quiz 571 p following 589 17906612 (Pubitemid 47506014)
40. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Calder PC, Mol Nutr Food Res 2008 52 885 897 10.1002/mnfr.200700289 18504706
41. Role of infant feeding practices in development of Crohn's disease in childhood. Koletzko S, Sherman P, Corey M, Griffiths A, Smith C, BMJ 1989 298 1617 1618 10.1136/bmj.298.6688.1617 2503151 (Pubitemid 19158541)
42. Mode of feeding and its effect on infant mortality and morbidity. Clavano NR, J Trop Pediatr 1982 28 287 293 10.1093/tropej/28.6.287 7154156 (Pubitemid 13176630)
43. A highly sensitive and selective method for the determination of Leukotriene B4 in human plasma by negative ion chemical ionization/gas chromatography/tandem mass spectrometry. Takamoto M, Yano T, Shintani T, Hiraku S, J Pharm Biomed Anal 1995 13 1465 1472 10.1016/0731-7085(95)01583-3 8788131 (Pubitemid 26022807)
44. Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study. Kakutani S, Ishikura Y, Tateishi N, Horikawa C, Tokuda H, Kontani M, Kawashima H, Sakakibara Y, Kiso Y, Shibata H, Morita I, Lipids Health Dis 2011 10 241 10.1186/1476-511X-10-241 22188761
45. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Mas E, Croft KD, Zahra P, Barden A, Mori TA, Clin Chem 2012 58 1476 1484 10.1373/clinchem.2012.190199 22912397
46. Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. Gomolka B, Siegert E, Blossey K, Schunck WH, Rothe M, Weylandt KH, Prostaglandins Other Lipid Mediat 2011 94 81 87 10.1016/j.prostaglandins.2010.12.006 21236358
47. Prostaglandins in human milk. Lucas A, Mitchell MD, Arch Dis Child 1980 55 950 952 10.1136/adc.55.12.950 7458394 (Pubitemid 11217556)
48. Resolution of inflammation: the beginning programs the end. Serhan CN, Savill J, Nat Immunol 2005 6 1191 1197 10.1038/ni1276 16369558 (Pubitemid 43045627)
49. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN, Proc Natl Acad Sci USA 2005 102 7671 7676 10.1073/pnas.0409271102 15890784 (Pubitemid 40741029)
50. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Ishida T, Yoshida M, Arita M, Nishitani Y, Nishiumi S, Masuda A, Mizuno S, Takagawa T, Morita Y, Kutsumi H, et al. Inflamm Bowel Dis 2010 16 87 95 10.1002/ibd.21029 19572372
51. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Fiorucci S, Wallace JL, Mencarelli A, Distrutti E, Rizzo G, Farneti S, Morelli A, Tseng JL, Suramanyam B, Guilford WJ, Parkinson JF, Proc Natl Acad Sci USA 2004 101 15736 15741 10.1073/pnas.0404722101 15505205 (Pubitemid 39473557)
52. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB, J Immunol 2011 187 1957 1969 10.4049/jimmunol.1101305 21724996
53. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, Scully M, Bruyninckx WJ, Colgan SP, Proc Natl Acad Sci USA 2010 107 14298 14303 10.1073/pnas.0914730107 20660763
54. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN, Proc Natl Acad Sci USA 2010 107 1660 1665 10.1073/pnas.0907342107 20080636
55. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L- phenylalanine. Lee TH, Horton CE, Kyan-Aung U, Haskard D, Crea AE, Spur BW, Clin Sci (Lond) 1989 77 195 203 (Pubitemid 19203563)
56. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Schwab JM, Chiang N, Arita M, Serhan CN, Nature 2007 447 869 874 10.1038/nature05877 17568749 (Pubitemid 46920139)
57. Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production. Prescott D, McKay DM, Am J Physiol Gastrointest Liver Physiol 2011 301 487 G497 10.1152/ajpgi.00042.2011 21659618
58. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. Gewirtz AT, McCormick B, Neish AS, Petasis NA, Gronert K, Serhan CN, Madara JL, J Clin Invest 1998 101 1860 1869 10.1172/JCI1339 9576749 (Pubitemid 28226104)
59. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, et al. Nat Immunol 2004 5 388 392 10.1038/ni1056 15034576 (Pubitemid 38500087)
60. Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronchiolitis. Dixon DL, Griggs KM, Forsyth KD, Bersten AD, Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology 2010 21 691 e696 10.1111/j.1399-3038.2010. 01011.x
61. Necrotizing enterocolitis: a multifactorial disease with no cure. Schnabl KL, Van Aerde JE, Thomson AB, Clandinin MT, World journal of gastroenterology: WJG 2008 14 2142 2161 10.3748/wjg.14.2142 18407587
62. Human milk versus formula feeding among preterm infants: short-term outcomes. Maayan-Metzger A, Avivi S, Schushan-Eisen I, Kuint J, Am J Perinatol 2012 29 121 126 22094917
63. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR, Nature medicine 2010 16 592 597 591p following 597 10.1038/nm.2123 20383154
64. Polyunsaturated fatty acid concentrations in human hindmilk are stable throughout 12-months of lactation and provide a sustained intake to the infant during exclusive breastfeeding: an Italian study. Marangoni F, Agostoni C, Lammardo AM, Giovannini M, Galli C, Riva E, Br J Nutr 2000 84 103 109 10961166 (Pubitemid 30611673)
65. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF, Prog Lipid Res 2001 40 1 94 10.1016/S0163-7827(00)00017-5 11137568 (Pubitemid 32008650)
66. Biochemistry of human milk in early lactation. Harzer G, Haug M, Bindels JG, Z Ernährungswiss 1986 25 77 90 (Pubitemid 16099286)
67. Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. Lauritzen L, Carlson SE, Matern Child Nutr 2011 7 Suppl 2 41 58 21366866
68. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I, Decsi T, Dudenhausen JW, Dupont C, Forsyth S, et al. J Perinat Med 2008 36 5 14 18184094
69. Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants. Lin YH, Llanos A, Mena P, Uauy R, Salem N Jr, Pawlosky RJ, Am J Clin Nutr 2010 92 284 293 10.3945/ajcn.2009.28779 20534748
70. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Cunnane SC, Francescutti V, Brenna JT, Crawford MA, Lipids 2000 35 105 111 10.1007/s11745-000-0501-6 10695931 (Pubitemid 30084637)
71. Comparison between the essential fatty acid status of preterm and full-term infants, measured in umbilical vessel walls. Foreman-van Drongelen MM, al MD, van Houwelingen AC, Blanco CE, Hornstra G, Early human development 1995 42 241 251 10.1016/0378-3782(95)01656-N 7493590
72. Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Uauy R, Mena P, Wegher B, Nieto S, Salem N Jr, Pediatr Res 2000 47 127 135 10.1203/00006450-200001000-00022 10625093 (Pubitemid 30038902)
73. Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates. Field CJ, Van Aerde JE, Robinson LE, Clandinin MT, Br J Nutr 2008 99 91 99 17640422
74. Polyunsaturated fatty acids and T-cell function: implications for the neonate. Field CJ, Clandinin MT, Van Aerde JE, Lipids 2001 36 1025 1032 10.1007/s11745-001-0813-6 11724454 (Pubitemid 33065204)
75. Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor N, Soler B, Mitmesser SH, Ferguson P, Lifschitz C, Clin Pediatr 2006 45 850 855 10.1177/1073858406289801 (Pubitemid 44570034)
76. Toddler formula supplemented with docosahexaenoic acid (DHA) improves DHA status and respiratory health in a randomized, double-blind, controlled trial of US children less than 3 years of age. Minns LM, Kerling EH, Neely MR, Sullivan DK, Wampler JL, Harris CL, Berseth CL, Carlson SE, Prostaglandins Leukot Essent Fatty Acids 2010 82 287 293 10.1016/j.plefa.2010.02.009 20207123
77. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Furuhjelm C, Warstedt K, Larsson J, Fredriksson M, Bottcher MF, Falth-Magnusson K, Duchen K, Acta Paediatr 2009 98 1461 1467 10.1111/j.1651-2227.2009.01355.x 19489765
78. Atopic sensitization during the first year of life in relation to long chain polyunsaturated fatty acid levels in human milk. Duchen K, Yu G, Bjorksten B, Pediatr Res 1998 44 478 484 10.1203/00006450-199810000-00003 9773834 (Pubitemid 28447331)
79. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, Serhan CN, Kang JX, Proc Natl Acad Sci USA 2006 103 11276 11281 10.1073/pnas.0601280103 16847262 (Pubitemid 44156509)
80. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, Martinez-Clemente M, Arroyo V, Claria J, J Immunol 2011 187 5408 5418 10.4049/jimmunol.1100225 22013115
81. 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration. Danielsson KN, Rydberg EK, Ingelsten M, Akyurek LM, Jirholt P, Ullstrom C, Forsberg GB, Boren J, Wiklund O, Hulten LM, Atherosclerosis 2008 199 34 40 10.1016/j.atherosclerosis.2007.10.027 18067895
82. High expression of human 15-lipoxygenase induces NF-kappaB-mediated expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and T-cell adhesion on human endothelial cells. Viita H, Sen CK, Roy S, Siljamaki T, Nikkari T, Yla-Herttuala S, Antioxid Redox Signal 1999 1 83 96 10.1089/ars.1999.1.1-83 11225735 (Pubitemid 129619765)
83. Plasma and red blood cell fatty acids in peroxisomal disorders. Moser AB, Jones DS, Raymond GV, Moser HW, Neurochem Res 1999 24 187 197 10.1023/A:1022549618333 9972864 (Pubitemid 29067959)
84. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Yang R, Chiang N, Oh SF, Serhan CN, et al. Current protocols in immunology Somerset: John Wiley & Sons, Coligan John E, 2011 Chapter 14: Unit 14 26
85. Lipoxin A Stereochemistry and biosynthesis. Serhan CN, Nicolaou KC, Webber SE, Veale CA, Dahlen SE, Puustinen TJ, Samuelsson B, J Biol Chem 1986 261 16340 16345 3097008
86. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN, J Biol Chem 2007 282 9323 9334 10.1074/jbc.M609212200 17244615 (Pubitemid 47104612)